warning

Alert: Because flu cases are on the rise, children 12 and younger will be restricted from visiting hospitals and certain inpatient facilities. Learn more.

Research and Clinical Trials

Title  
COG ANBL00B1: Neuroblastoma Biology Studies
Brief Description  
The purpose of this study is to evaluate the factors currently used for risk-group assignment (DNA content, MYCN copy number, and tumor histology) in patients with newly diagnosed neuroblastoma or ganglioneuroblastoma.
Who may be Eligible  
Please contact us for eligibility criteria.
Speciality/Disorder  
Brain and Nervous System
Status  
OPEN
Start Date  
12/04/2013
IRB Number  
ANBL00B1
Principal Investigator  
Kaplan, Joel Adam
Contact Name  
Katie C Brown

For More Information, Contact  Katie  C, Brown
Phone:  980-442-2325 Fax:    
Email:  Kathryn.Brown@carolinashealthcare.org
Address:1021 Morehead Medical Drive Suite 2200 Charlotte, NC 28204
Close